Home > Hanna Rodriguez Coleman, M.D.

Hanna Rodriguez Coleman, M.D.

Hanna Rodriguez Coleman

National Eye Institute (NEI),
National Institutes of Health

  • National Eye Health Education Program Spokesperson

New York Presbyterian Hospital - Columbia, New York

  • Assistant Clinical Professor

Digital Angiography Reading Center New York, New York

  • Representative and senior consultant


  • Ophthalmology
  • Retinal diseases
  • Diabetic macular edema
  • Age-related macular degeneration

Current Activities

Dr. Coleman is fluent in English and Spanish. She is currently an assistant clinical professor at New York Presbyterian Hospital and a senior consultant for the interpretation of Fluorescein and indocyanine green angiograms at the Digital Angiography Reading Center in New York. Dr. Coleman is a member of the American Academy of Ophthalmology, New York State Ophthalmological Society and the American Medical Association.


Dr. Coleman is the author of more than 25 research articles based on her studies and published in the American Journal of Ophthalmology, Archives of Ophthalmology, The Lancet, Ophthalmology, Proceedings of the National Academy of Sciences, and Retina.

Research Highlights

Dr. Coleman has served as Principal Investigator for several NEI studies including:

  • Pilot study of Intravitreal Injection of Triamcinolone Acetonide Formulation for Retinal Vascular Disorders (TACPF)
  • Phase III, multicenter trial - Standard Care vs. Corticosteroid for Retinal Vein Occlusion (SCORE)
  • Phase II/III, multicenter randomized clinical trial to study the effects of preservative-free triamcinolone acetonide as an Adjunct to Photodynamic therapy in Participants with Neovascular Age-related Macular Degeneration (VERTACL)
  • Phase I study of Intravitreal Injections Versus Anterior Sub-tenon Injections of Triamcinolone Acetonide Formulation for Macular Edema in Retinal Disorders (EXTAC)